1. Home
  2. NDSN vs MEDP Comparison

NDSN vs MEDP Comparison

Compare NDSN & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nordson Corporation

NDSN

Nordson Corporation

HOLD

Current Price

$278.89

Market Cap

15.1B

Sector

Industrials

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$518.62

Market Cap

14.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NDSN
MEDP
Founded
1935
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1B
14.9B
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
NDSN
MEDP
Price
$278.89
$518.62
Analyst Decision
Buy
Hold
Analyst Count
5
13
Target Price
$320.80
$498.25
AVG Volume (30 Days)
269.3K
260.5K
Earning Date
05-27-2026
04-22-2026
Dividend Yield
1.18%
N/A
EPS Growth
4.93
20.98
EPS
2.38
15.28
Revenue
$2,254,668,000.00
N/A
Revenue This Year
$7.71
$13.19
Revenue Next Year
$4.96
$7.75
P/E Ratio
$116.87
$32.79
Revenue Growth
9.08
N/A
52 Week Low
$174.61
$250.05
52 Week High
$305.28
$628.92

Technical Indicators

Market Signals
Indicator
NDSN
MEDP
Relative Strength Index (RSI) 58.60 63.03
Support Level $265.04 $489.09
Resistance Level $305.28 $622.32
Average True Range (ATR) 5.84 16.86
MACD 2.21 4.90
Stochastic Oscillator 90.99 87.95

Price Performance

Historical Comparison
NDSN
MEDP

About NDSN Nordson Corporation

Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.8 billion in revenue in its fiscal 2025.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: